MALAT1 is involved in the pathophysiological process of PCOS by modulating TGFβ signaling in granulosa cells - PubMed (original) (raw)
MALAT1 is involved in the pathophysiological process of PCOS by modulating TGFβ signaling in granulosa cells
Dan Zhang et al. Mol Cell Endocrinol. 2020.
Abstract
Polycystic ovary syndrome (PCOS) is an endocrine disorder, the etiology of which is complex and unclear. Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) is a conserved long non-coding RNA which has been found to play a role in the pathophysiological process of reproductive system diseases, such as endometriosis and pregnancy loss. However, the role of MALAT1 in PCOS is still unknown. In this study, reduced MALAT1 expression was found in granulosa cells (GCs) from 68 patients with PCOS and 30 healthy controls, which relates to upregulated cell proliferation and downregulated apoptosis. Using phosphorylation pathway profiling array, MALAT1 reduction was identified to contribute to the repression of transforming growth factor beta (TGFβ) signaling in GCs. Subsequently, MALAT1 was confirmed to function as a competing endogenous RNA (ceRNA), interacting with miR-125b and miR-203a. Meanwhile, miR-125b and miR-203a was identified as two novel TGFβ signaling negative regulators by targeting TGFBR1 and TGFBR2. Finally, MALAT1 knockdown was found to induce the upregulation of miR-125b and miR-203a, which further repressed TGFβ signaling, changed some downstream gene expression, and resulted in a disordered cell cycle. In conclusion, MALAT1 reduction was identified in GCs, which may contribute to the pathophysiological processes of PCOS by regulating TGFβ signaling through sponging miR-125b and miR-203a.
Keywords: Granulosa cell; Long non-coding RNA; Metastasis-associated lung adenocarcinoma transcript 1; Polycystic ovary syndrome; microRNA.
Copyright © 2019 Elsevier B.V. All rights reserved.
Similar articles
- Down-regulation of MALAT1 aggravates polycystic ovary syndrome by regulating MiR-302d-3p-mediated leukemia inhibitory factor activity.
Chen Y, Chen Y, Cui X, He Q, Li H. Chen Y, et al. Life Sci. 2021 Jul 15;277:119076. doi: 10.1016/j.lfs.2021.119076. Epub 2021 Jan 16. Life Sci. 2021. PMID: 33465389 - Dysregulated miR-142, -33b and -423 in granulosa cells target TGFBR1 and SMAD7: a possible role in polycystic ovary syndrome.
Li Y, Xiang Y, Song Y, Wan L, Yu G, Tan L. Li Y, et al. Mol Hum Reprod. 2019 Oct 28;25(10):638-646. doi: 10.1093/molehr/gaz014. Mol Hum Reprod. 2019. PMID: 30865275 - Effect of lncRNA MALAT1 on the Granulosa Cell Proliferation and Pregnancy Outcome in Patients With PCOS.
Tu M, Wu Y, Wang F, Huang Y, Qian Y, Li J, Lv P, Ying Y, Liu J, Liu Y, Zhang R, Zhao W, Zhang D. Tu M, et al. Front Endocrinol (Lausanne). 2022 Apr 27;13:825431. doi: 10.3389/fendo.2022.825431. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35573984 Free PMC article. - Long noncoding RNAs as a piece of polycystic ovary syndrome puzzle.
Abolghasemi M, Mahjoub S. Abolghasemi M, et al. Mol Biol Rep. 2021 Apr;48(4):3845-3851. doi: 10.1007/s11033-021-06196-1. Epub 2021 May 15. Mol Biol Rep. 2021. PMID: 33993404 Review. - Long non-coding RNAs in ovarian granulosa cells.
Tu J, Chen Y, Li Z, Yang H, Chen H, Yu Z. Tu J, et al. J Ovarian Res. 2020 Jun 5;13(1):63. doi: 10.1186/s13048-020-00663-2. J Ovarian Res. 2020. PMID: 32503679 Free PMC article. Review.
Cited by
- LncRNA NEAT1 and MALAT1 are involved in polycystic ovary syndrome pathogenesis by functioning as competing endogenous RNAs to control the expression of PCOS-related target genes.
ElMonier AA, El-Boghdady NA, Fahim SA, Sabry D, Elsetohy KA, Shaheen AA. ElMonier AA, et al. Noncoding RNA Res. 2023 Mar 3;8(2):263-271. doi: 10.1016/j.ncrna.2023.02.008. eCollection 2023 Jun. Noncoding RNA Res. 2023. PMID: 36935861 Free PMC article. - Immune Dysfunction Mediated by the ceRNA Regulatory Network in Human Placenta Tissue of Intrahepatic Cholestasis Pregnancy.
Wang Y, Tang Y, Yang X, Xu J, Chen Y, Xu J, Hu S, Yi P. Wang Y, et al. Front Immunol. 2022 Jun 24;13:883971. doi: 10.3389/fimmu.2022.883971. eCollection 2022. Front Immunol. 2022. PMID: 35812382 Free PMC article. - Biomarker potential of competing endogenous RNA networks in Polycystic Ovary Syndrome (PCOS).
Heidarzadehpilehrood R, Pirhoushiaran M. Heidarzadehpilehrood R, et al. Noncoding RNA Res. 2024 Jan 17;9(2):624-640. doi: 10.1016/j.ncrna.2024.01.002. eCollection 2024 Jun. Noncoding RNA Res. 2024. PMID: 38571815 Free PMC article. Review. - MALAT1 expression in granulosa cells in PCOS patients with different phenotypes.
Li S, Li Y, Yan X, Zhao S, Yang Z, Wang Y, Gao X, Chen ZJ. Li S, et al. Sci Rep. 2024 Feb 29;14(1):5019. doi: 10.1038/s41598-024-55760-9. Sci Rep. 2024. PMID: 38424234 Free PMC article. - AT2R activation increases in vitro angiogenesis in pregnant human uterine artery endothelial cells.
Mishra JS, Chen DB, Kumar S. Mishra JS, et al. PLoS One. 2022 Apr 29;17(4):e0267826. doi: 10.1371/journal.pone.0267826. eCollection 2022. PLoS One. 2022. PMID: 35486619 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical